MicroRNAs and multiple sclerosis: from physiopathology toward therapy
- 21 September 2013
- journal article
- review article
- Published by Informa Healthcare in Emerging Therapeutic Targets
- Vol. 17 (12), 1497-1507
- https://doi.org/10.1517/14728222.2013.838219
Abstract
Introduction: MicroRNAs (miRNAs) are an emerging group of small noncoding RNAs that regulate gene expression posttranscriptionally, by targeting messenger RNAs (mRNAs) for translational repression or degradation. They have roles in multiple facets of immunity, from regulation of cell development to activation and function in immune responses. Recent evidence underlines an involvement of miRNAs in the pathogenesis of autoimmune diseases as well as multiple sclerosis (MS). Areas covered: In this review, the current knowledge of miRNA biogenesis, diverse roles of miRNAs in different cells that could be involved in the process of the disease, and their potential therapeutic applications are summarized. The authors searched MEDLINE and Science direct databases. Expert opinion: The miRNAs in central nervous system lesions and peripheral blood are potential biomarkers for diagnostic and prognostic use. Also, miRNA mimics, small-molecule inhibitors of specific miRNAs, and antisense oligonucleotides could be therapeutic weapons that facilitate us to combat the disease.Keywords
This publication has 69 references indexed in Scilit:
- MicroRNAs in neuronal function and dysfunctionTrends in Neurosciences, 2012
- Rational Design of Therapeutic siRNAs: Minimizing Off-targeting Potential to Improve the Safety of RNAi Therapy for Huntington's DiseaseMolecular Therapy, 2011
- Role of microRNA-155 in autoimmunityCytokine & Growth Factor Reviews, 2011
- MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseasesTranslational Research, 2011
- Mediators of oligodendrocyte differentiation during remyelinationFEBS Letters, 2011
- MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α–PU.1 pathwayNature Medicine, 2010
- MicroRNA-155 Promotes Autoimmune Inflammation by Enhancing Inflammatory T Cell DevelopmentImmunity, 2010
- Altered miRNA expression in T regulatory cells in course of multiple sclerosisJournal of Neuroimmunology, 2010
- Dicer1 and miR-219 Are Required for Normal Oligodendrocyte Differentiation and MyelinationNeuron, 2010
- Alterations of the microRNA network cause neurodegenerative diseaseTrends in Neurosciences, 2009